Megakaryocytes are large, polyploid cells residing in the bone marrow, where they serve as the primary source of platelets, small, anucleate blood cells essential for clot formation and vascular repair. These specialized cells originate from hematopoietic stem cells, which are multipotent stem cells responsible for generating all blood cell types. The journey from stem cells to mature megakaryocytes involves a tightly regulated sequence of differentiation and maturation events within the bone marrow microenvironment. Understanding megakaryocyte biology not only sheds light on normal blood cell development but also provides critical insights into hematologic diseases such as thrombocytopenias, myelodysplastic syndromes, and chronic myeloproliferative disorders.

Megakaryocyte development

Megakaryocyte development, also known as megakaryopoiesis, is initiated when hematopoietic stem cells commit to the megakaryocytic lineage. This commitment is orchestrated by a network of transcription factors and signaling molecules, with thrombopoietin (TPO) acting as the central cytokine driving megakaryocyte proliferation and maturation. As megakaryocytes progress through development, they undergo endomitosis, a distinctive process where the cell replicates its DNA multiple times without cell division, resulting in high ploidy and large cell size. This unique adaptation enables each megakaryocyte to produce thousands of platelets, supporting the body’s ongoing need for effective hemostasis and vascular integrity.

Platelet production

The final stage of megakaryopoiesis is platelet production, a process that takes place when mature megakaryocytes extend long, branching proplatelets into the blood vessels of the bone marrow. These proplatelets are fragmented by the shear forces of blood flow, releasing individual platelets into the circulation. Platelets then circulate throughout the body, where they play a vital role in maintaining vascular health and preventing bleeding. The balance between platelet production by mature megakaryocytes and the clearance of aged or damaged platelets is tightly regulated to ensure proper blood clotting and to prevent disorders related to abnormal platelet counts.

CD36

CD36 is a transmembrane glycoprotein expressed on the surface of megakaryocytes and platelets. It plays a role in lipid metabolism and cellular adhesion, making it a useful marker in hematopoietic research. Its expression helps distinguish platelet lineage cells and supports studies in thrombosis, inflammation, and cardiovascular biology. CD36 is also being explored in diagnostic and therapeutic contexts, particularly in relation to platelet function and immune response. Researchers continue to investigate its broader implications across blood cell development and disease pathways.

Figure 1. Immunocytochemistry/ Immunofluorescence - Anti-CD36 antibody [EPR22509-40] (ab252922).

Recommended products

CD41

CD41, or integrin alpha-IIb, is a surface protein expressed during early megakaryocyte development and maintained on mature platelets. It forms part of the glycoprotein IIb/IIIa complex, which mediates platelet aggregation and adhesion. CD41 is widely used in flow cytometry and immunohistochemistry to identify cells of the platelet lineage. Its consistent expression makes it a reliable marker in studies of thrombopoiesis, platelet biology, and related disorders. Ongoing research continues to explore its role in hematopoietic differentiation and immune interactions.

Figure 2. Flow Cytometry - Anti-CD41 antibody [M148] (ab11024).

Recommended products

CD42a

CD42a, also known as glycoprotein IX, is a component of the GPIb-IX-V complex found on platelets and late-stage megakaryocytes. It contributes to platelet adhesion by interacting with von Willebrand factor, supporting vascular integrity and hemostasis. CD42a is commonly used in flow cytometry to identify mature platelet-lineage cells and distinguish them from other hematopoietic populations. Its expression pattern makes it a valuable tool in studies of thrombopoiesis, platelet disorders, and immune cell interactions, helping researchers explore blood cell development and function.

Figure 3. Flow Cytometry - APC Anti-CD42a/GP-IX antibody [GR-P] (ab270643).

Recommended products

CD42b

CD42b, also known as glycoprotein Ib alpha, is a key component of the GPIb-IX-V complex expressed on platelets and mature megakaryocytes. It binds von Willebrand factor, supporting platelet adhesion under shear stress. CD42b is widely used in flow cytometry and immunophenotyping to identify platelet-lineage cells and assess maturation stages. Its expression helps distinguish megakaryocytic cells from other hematopoietic populations, aiding research into thrombopoiesis, platelet function, and related disorders. CD42b continues to be a valuable marker in both basic and translational hematology studies.

Figure 4. Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD42b antibody [SP219] (ab183345).

Recommended products

CD61

CD61, also known as integrin beta-3, is a transmembrane protein expressed on platelets and megakaryocytes. It pairs with CD41 to form the glycoprotein IIb/IIIa complex, which supports platelet aggregation and adhesion. CD61 is widely used in flow cytometry to identify cells of the megakaryocytic lineage and monitor platelet development. Its expression helps distinguish platelet precursors and mature cells, contributing to research in thrombopoiesis, clotting disorders, and immune regulation. CD61 remains a reliable marker in both basic and applied hematology studies.

Figure 5. Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Integrin beta 3 antibody [VI-PL2] (ab110131).

Recommended products

References

1. Chang, Y., Bluteau, D., Debili, N., Vainchenker, W. From hematopoietic stem cells to platelets J. Thromb. Haemost. 5 ,318-327 (2007)
2. Novershtern, N., et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis  Cell  144 ,296-309 (2011)
3. Deutsch, V. R., Tomer, A. Megakaryocyte development and platelet production  Br. J. Haematol.  134 ,453-466 (2006)
4. Van Velzen, J. F., Laros-Van Gorkom, B. A. P., Pop, G. A. M., Van Heerde, W. L. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers  Thromb. Res.  130 ,92-98 (2012)